Gen-Probe Walks Away with Patent Victory

Gen-Probe Walks Away with Patent Victory

Client News

Related Solutions

Providing comprehensive solutions for the acquisition, enforcement and protection of IP.
A global team handling highly complex and sensitive matters in all aspects of litigation.
Clients trust us to protect their most important intellectual property matters.

WilmerHale won a significant case for client Gen-Probe Incorporated when the US Court of Appeals for the Federal Circuit affirmed that a patent owned by plaintiff-appellant, Enzo Biochem, Inc., was invalid under the on-sale bar.

The patent at issue claimed compositions and methods related to DNA assays, specific to the detection of gonorrhea. The Court held that a contract between Enzo and another company—under which Enzo was obligated to provide that company with a percentage of its requirements for gonorrhea-specific DNA assays—constituted a “commercial offer for sale” under the relevant statute, and that Enzo’s DNA assay was “ready for patenting” more than one year before it filed its patent application.

William Lee argued the appeal and was assisted on the brief by William McElwain, Henry Wixon, Nina Tallon and Gregory Lantier.

To learn more about Gen-Probe, click here.

Notice

We appreciate your interest in WilmerHale. While we are pleased to have you contact us, please keep in mind that merely contacting WilmerHale does not create an attorney-client relationship. Such a relationship will not arise until the Firm agrees in writing to represent you in connection with a particular matter. Importantly, unless and until this has occurred, you should not provide us with any confidential information, and we have no duty to keep confidential any information that we may receive from you. Thank you for your understanding.

I Accept Cancel